The expression of the mdm2 gene may be related to the aberration of the p53 gene in human hepatocellular carcinoma

Journal of Cancer Research and Clinical Oncology

Volumn 124, Issue 5, 1998, Pages 253-258

  Qiu, Shuang Jian ^a   Ye, Sheng Long ^a   Wu, Zhi Quan ^a   Tang, Zhao You ^a   Liu, Yin Kun ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

Hepatocellular carcinoma; mdm2; p53; Tumor invasiveness

Indexed keywords

GENE PRODUCT; PROTEIN P53;

ADULT; ARTICLE; AUTOREGULATION; CANCER INVASION; CANCER RECURRENCE; CLINICAL ARTICLE; CONTROLLED STUDY; FEEDBACK SYSTEM; FEMALE; GENE EXPRESSION; GENE MUTATION; HUMAN; HUMAN TISSUE; LIVER CELL CARCINOMA; MALE; ONCOGENE; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

ADULT; CARCINOMA, HEPATOCELLULAR; DNA PRIMERS; ELECTROPHORESIS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, P53; HUMANS; LIVER NEOPLASMS; MALE; MUTATION; NEOPLASM INVASIVENESS; NEOPLASM PROTEINS; NUCLEAR PROTEINS; POLYMERASE CHAIN REACTION; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-MDM2; RNA-DIRECTED DNA POLYMERASE; UP-REGULATION;

EID: 0031746179     PISSN: 01715216     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004320050162     Document Type: Article

References (45)

1. Barak Y, Juven T, Haffner R, Oren M (1993) mdm2 expression is induced by wild type p53 activity. EMBO J 12:461-468
2. Bressac B, Kew M, Wands J, Ozturk M (1991) Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa. Nature 350:429-431
3. Bueso-Ramos CE, Yang Y, Deleon E, McCown P, Stass SA, Albitar M (1993) The human MDM-2 oncogene is overexpressed in leukemias. Blood 82:2617-2623
4. Chen CY, Oliner JD, Zhan Q, Fornace AJ Jr, Vogelstein B, Kastan MB (1994) Interactions between p53 and MDM2 in a mammalian cell cycle checkpoint pathway. Proc Natl Acad Sci USA 91:2684-2688
5. Cho Y, Gorina S, Jeffrey PD, Pavletich NP (1994) Crystal structure of a p53 tumour suppressor-DNA complex: understanding tumourigenic mutations. Science 265:346-355
6. Chomczynski P, Sacchi N (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159
7. Fakharzadeh SS, Trusko SP, George DL (1991) Tumorigenic potential associated with enhanced expression of a gene that is amplified in a mouse tumor cell line. EMBO J 10:1565-1569
8. Florenes VA, Malandsmo GM, Forus A, Andreassen A, Myklebost O, Fodstad Q (1994) MDM2 gene amplification and transcript levels in human sarcomas: relationship to TP53 gene status. J Natl Cancer Inst 86:1297-1302
9. Greenblatt MS, Bennett WP, Hollstein M, Harris CC (1994) Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res 54:4855-4878
10. Haupt Y, Barak Y, Oren M (1996) Cell type-specific inhibition of p53-mediated apoptosis by mdm2. EMBO J 15:1596-1606
11. Haupt Y, Maya R, Kazaz A, Oren M (1997) Mdm2 promotes the rapid degradation of p53. Nature 387:296-299
12. Hsu HC, Tseng HJ, Lai PL, Lee PH, Peng SY (1993) Expression of p53 gene in 184 unifocal hepatocellular carcinomas: association with tumor growth and invasiveness. Cancer Res 53:4691-4694
13. Hsu IC, Metcalf RA, Sun T, Welsh JA, Wang NJ, Harris CC (1991) Mutational hotspot in the p53 gene in human hepatocellular carcinomas. Nature 350:427-428
14. Jones SN, Roe AE, Donehower LA, Bradley A (1995) Rescue of embryonic lethality in Mdm-2 deficient mice by absence of p53. Nature 378:206-208
15. Kondo S, Morimura T, Barnett GH, Kondo Y, Peterson JW, Kaakaji R, Takeuchi J, Toms SA, Liu J, Werbel B, Barna BP (1996) The transforming activities of MDM2 in cultured neonatal rat astrocytes. Oncogene 13:1773-1779
16. Kubbutat MHG, Jones SN, Vousden KH (1997) Regulation of p53 stability by Mdm2. Nature 387:299-303
17. Kussie PH, Gorina S, Marechal V, Elenbaas B, Moreau J, Levine AJ, Pavletich NP (1996) Structure of the MDM2 oncoprotein hound to the p53 tumor suppressor transactivation domain. Science 274:948-953
18. Ladanyi M, Cha C, Lewis R, Jhanwar SC, Huvos AG, Healey JH (1993) MDM2 gene amplification in metastatic osteosarcoma. Cancer Res 53:16-18
19. Lane DP (1994) p53 and human cancers. Br Med Bull 50:582-599
20. Leach FS, Tokino T, Meltzer P, Burrell M, Oliner JD, Smith S, Hill DE, Sidransky D, Kinzler KW, Vogelstein B (1993) p53 mutation and MDM2 amplification in human soft tissue sarcomas. Cancer Res 53:2231-2234
21. Lianes P, Orlow I, Zhang ZF, Oliva MR, Sarkis AS, Reuter VE, Cordon-Cardo C (1994) Altered patterns of MDM2 and TP53 expression in human bladder cancer. J Natl Cancer Inst 86:1325-1330
22. Lonardo F, Ueda T, Huvos AG, Healey J, Ladanyi M (1997) p53 and MDM2 alterations in osteosarcomas. Cancer 79:1541-1547
23. Marchetti A, Buttitta F, Girlando S, Palma PD, Pellegrini S, Fina P, Doglioni C, Bevilacqua G, Barbareschi M (1995) mdm2 gene alterations and mdm2 protein expression in breast carcinomas. J Pathol 175:31-38
24. Martin K, Trouche D, Hagemeier C, Sorensen TS, Thangue NBL, Kouzarides T (1995) Stimulation of E2F1/DP1 transcriptional activity by MDM2 oncoprotein. Nature 375:691-694
25. McCann AH, Kirley A, Carney DN, Corbally N, Magee HM, Keating G, Dervan PA (1995) Amplification of the MDM2 gene in human breast cancer and its association with MDM2 and p53 protein status. Br J Cancer 71:981-985
26. Meltzer PS (1994) MDM2 and p53: a question of balance. J Natl Cancer Inst 86:1265-1266
27. Momand J, Zambetti GP (1997) Mdm-2: "Big brother" of p53. J Cell Biochem 64:343-352
28. Momand J, Zambetti GP, Olson DC, George D, Levine AJ (1992) The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation. Cell 69:1237-1245
29. Murakami Y, Hayashi K, Hirohashi S, Sekiya T (1991) Aberrations of the tumor suppressor p53 and retinoblastoma genes in human hepatocellular carcinoma. Cancer Res 51:5520-5525
30. Nishida N, Fukuda Y, Kokuryu H, Toguchida J, Yandell DW, Ikenega M, Imura H, Ishizaki K (1993) Role and mutational heterogeneity of the p53 gene in hepatocellular carcinoma. Cancer Res 53:368-372
31. Oca Luna RM de, Wagner DS, Lozano G (1995) Rescue of early embryonic lethality in mdm2-deficient mice by deletion of p53. Nature 378:203-206
32. Oliner JD, Kinzler KW, Meltzer PS, George DL, Vogelstein B (1992) Amplification of a gene encoding a p53-associated protein in human sarcomas. Nature 358:80-83
33. Oliner JD, Pietenpol JA, Thiagalingam S, Gyuris J, Kinzler KW, Vogelstein B (1993) Oncoprotein MDM2 conceals the activation domain of tumor suppressor p53. Nature 362:857-860
34. Perry ME, Piette J, Zawadzki JA, Harvey D, Levine AJ (1993) The mdm2 gene is induced in response to UV light in a p53-dependent manner. Proc Natl Acad Sci USA 90:11623-11627
35. Picksley SM, Spicer JF, Barnes DM, Lane DP (1996) The p53-MDM2 interaction in a cancer-prone family, and the identification of a novel therapeutic target. Acta Oncol 35:429-434
36. Pietenpol JA, Tokino T, Thiagalingam El-Deiry W, Kinzler KW, Vogelstein B (1994) Sequence-specific transcriptional activation is essential for growth suppression by p53. Proc Natl Acad Sci USA 91:1998-2002
37. Qin LX, Tang ZY, Liu KD, Ye SL, Zhou G (1995) p53 mutations may be related to tumor invasivencss of human hepatocellular carcinoma in China. Oncol Rep 2:1175-1179
38. Reifenberger G, Liu L, Ichimura K, Schmidt EE, Collins VP (1993) Amplification and overexpression of the MDM2 gene in a subset of human malignant gliomas without p53 mutations. Cancer Res 53:2736-2739
39. Sheikh MS, Shao ZM, Hussain A, Fontana JA (1993) The p53-binding protein MDM2 gene is differentially expressed in human breast carcinoma. Cancer Res 53:3226-3228
40. Tang ZY (1996) Studies on small hepatocellular carcinoma-clinical aspect and molecular biology. Hepatol Rapid Lit Rev 26:XI-XVI
41. Watanabe T, Hotta T, Ichikawa A, Kinoshita T, Nagai H, Uchida T, Murate T, Saito H (1994) The MDM2 oncogene overexpression in chronic lymphocytic leukemia and low-grade lymphoma of B-cell origin. Blood 84:3158-3165
42. Xiao ZX, Chen J, Levine AJ, Modjtahedl N, Xing J, Sellers WR, Livingston DM (1995) Interaction between the retinoblastoma protein and the oncoprotein MDM2. Nature 375:694-698
43. Zhao P, Yang GH, Mao X (1993) A molecular pathological study of p53 gene in hepatocellular carcinoma. Chin J Pathol 22:16-18
44. Zheng YX, Yu YQ, Liu KD, Shi DR, Lu HF, Zou HQ, Bao WH (1996) Correlations between portal vein tumor thrombogenesis and expression of P53 and PCNA in hepatocellular carcinoma. Chin J Dig 16:75-78
45. Zhou XD, Tang ZY, Yu YQ, Yang BH, Lu JZ, Lin ZY, Ma ZC, Zhang BH (1994) Recurrence after resection of 2-fetoprotein-positive hepatocellular carcinoma. J Cancer Res Clin Oncol 120:369-373